Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.230
0.00 (0.00%)
Jun 18, 2025, 4:00 PM - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $83.12 million as of June 20, 2025. Its market cap has decreased by -65.74% in one year.
Market Cap
83.12M
Enterprise Value
-114.25M
1-Year Change
-65.74%
Ranking
Category
Stock Price
1.23
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $83.12M, a decrease of -79.39%. That is a compound annual growth rate of -33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 83.12M | -31.31% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |